Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Equity Ratio: 2019-2024

  • Burning Rock Biotech's Equity Ratio fell 11.20% to 0.66 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.66, marking a year-over-year decrease of 11.20%. This contributed to the annual value of 0.66 for FY2024, which is 11.20% down from last year.
  • Burning Rock Biotech's Equity Ratio amounted to 0.66 in Q4 2024, which was down 11.20% from 0.74 recorded in Q4 2023.
  • In the past 5 years, Burning Rock Biotech's Equity Ratio ranged from a high of 0.91 in Q4 2020 and a low of 0.66 during Q4 2024.
  • Over the past 3 years, Burning Rock Biotech's median Equity Ratio value was 0.73 (recorded in 2022), while the average stood at 0.71.
  • In the last 5 years, Burning Rock Biotech's Equity Ratio spiked by 186.43% in 2020 and then decreased by 11.20% in 2024.
  • Burning Rock Biotech's Equity Ratio (Quarterly) stood at 0.91 in 2020, then declined by 10.92% to 0.81 in 2021, then dropped by 9.90% to 0.73 in 2022, then increased by 1.26% to 0.74 in 2023, then declined by 11.20% to 0.66 in 2024.
  • Its last three reported values are 0.66 in Q4 2024, 0.74 for Q4 2023, and 0.73 during Q4 2022.